Clinical Trial Update: Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women

View source ↗

Summary

Real-world effectiveness and cardiovascular safety study of abaloparatide in postmenopausal women has completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopause

Drugs mentioned

• Abaloparatide (abaloparatide)

Snippet

Sponsor: Radius Health, Inc. | Conditions: Osteoporosis, Postmenopausal | Status: COMPLETED | Results posted: 2024-04-19